Figure 2From: Evaluation of patients’ expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index – the benefica study AR-PBI distribution in patients with AR after a 14-day treatment period with antihistamines (n = 3089). The percentage of patients is reported on the vertical axis while the patient benefit index (PBI) score is reported on the horizontal axis. This score ranges from 0 to 4 and is divided into 8 intervals.Back to article page